Published Date: 24 February 2015 No. of pages : 159

Global Oncology/Cancer

Drugs Market Forecast

2013 - 2020

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. However, high cost involved in new drug development coupled with threat of failure and adverse effects associated with cancer drugs therapies would restrain the growth of the market. Commercialization of advanced therapeutics such as targeted and immunotherapies would reduce the negative influence of restraints and fuel the market growth.

The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.

Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period.

Introduction to Oncology/Cancer Drugs Market

Introduction

Scope of the ReportKey Benefits

Key Audiences

KEY BENEFITS

The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on

The report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs market

The report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs market

Market conditions of cancer drugs market across all geographic regions are comprehensively analysed

Competitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographies

SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies

Table of Contents

1. INTRODUCTION

2. EXECUTIVE SUMMARY

3. MARKET OVERVIEW

4. GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY THERAPEUTIC MODALITIES

5. GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY CANCER TYPES

6. GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY GEOGRAPHY

7. COMPANY PROFILES

Global Oncology/Cancer Drugs Market Overview

1.Market Definition & Scope

2.Development of novel immuno-oncology drug products

3.Key findings

4.Porter’s five forces analysis

5.Value chain analysis

6.Government regulations and reimbursement

7.Patent analysis

8.Market share analysis, 2013

9. Clinical trials for oncology drugs

10.Market dynamics

 Global Oncology/Cancer Drugs Market By Therapeutic Modalities

GLOBAL ONCOLOGY/CAN

CER DRUGS MARKET BY

THERAPEUTIC MODALITIES

Chemotherapy

Targeted therapy

Immunotherapy (biologics therapy)

Hormonal therapy

Global Oncology/Cancer Drugs Market By Cancer Types

GLOBAL ONCOLOGY/CANCER DRUGS MARKET BY

CANCER TYPES

Blood cancer

Breast cancer

Gastrointestinal cancer

Prostate cancer

Respiratory/lung cancer

Skin cancer

Global  Oncology/Cancer Drugs Market By Geography

North America, Europe, Asia Pacific, LAMEA

Company Profiles

1.Amgen Inc.

2.Johnson and Johnson

3.Roche Diagnostics

4.GlaxoSmithKline PLC

5.Merck & Company

6.Novartis AG

7. Pfizer

8.Sanofi

9.Eli Lilly and Company

10. Celgene Corporation

Follow Us On

Thank You!For More Details

Visit us at

http://www.alliedmarketresearch.com/oncology-cancer-drugs-market